- Home
- CLNN vs ACXP Comparison
CLNN vs ACXP Comparison
Compare CLNN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- ACXP
- Stock Information
- Founded
- CLNN 2012
- ACXP 2017
- Country
- CLNN United States
- ACXP United States
- Employees
- CLNN N/A
- ACXP N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CLNN Health Care
- ACXP Health Care
- Exchange
- CLNN Nasdaq
- ACXP Nasdaq
- Market Cap
- CLNN 37.7M
- ACXP 31.4M
- IPO Year
- CLNN N/A
- ACXP 2021
- Fundamental
- Price
- CLNN $4.43
- ACXP $0.78
- Analyst Decision
- CLNN Strong Buy
- ACXP Strong Buy
- Analyst Count
- CLNN 4
- ACXP 1
- Target Price
- CLNN $55.25
- ACXP $12.00
- AVG Volume (30 Days)
- CLNN 47.6K
- ACXP 132.1K
- Earning Date
- CLNN 03-12-2025
- ACXP 03-14-2025
- Dividend Yield
- CLNN N/A
- ACXP N/A
- EPS Growth
- CLNN N/A
- ACXP N/A
- EPS
- CLNN N/A
- ACXP N/A
- Revenue
- CLNN $421,000.00
- ACXP N/A
- Revenue This Year
- CLNN N/A
- ACXP N/A
- Revenue Next Year
- CLNN N/A
- ACXP N/A
- P/E Ratio
- CLNN N/A
- ACXP N/A
- Revenue Growth
- CLNN N/A
- ACXP N/A
- 52 Week Low
- CLNN $3.82
- ACXP $0.67
- 52 Week High
- CLNN $10.40
- ACXP $3.35
- Technical
- Relative Strength Index (RSI)
- CLNN 42.58
- ACXP 49.91
- Support Level
- CLNN $4.15
- ACXP $0.67
- Resistance Level
- CLNN $4.99
- ACXP $0.76
- Average True Range (ATR)
- CLNN 0.28
- ACXP 0.04
- MACD
- CLNN 0.00
- ACXP 0.00
- Stochastic Oscillator
- CLNN 33.33
- ACXP 75.28
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.